<DOC>
	<DOCNO>NCT01060306</DOCNO>
	<brief_summary>PONTINA aim assess optical coherence tomography neointimal coverage biodegradable polymer-based Biolimus A9-eluting stent ( Biomatrix stent ) full drug elution polymer biodegradation ( 6 month ) , one month time-point ( 7 month ) , comparator , bare metal stent counterpart ( Gazelle stent ) 1 month implantation .</brief_summary>
	<brief_title>Optical Coherence Tomography Evaluation Biodegradable Polymer-based Drug-eluting Stent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>age &gt; 50 year de novo lesion lesion length &lt; 24 mm reference vessel diameter 3 mm low compliance dual antiplatelet therapy life expectancy &lt; 1 year allergy drug substance use prior , percutaneous coronary intervention chronic renal insufficiency low leave ventricle ejection fraction ( &lt; 35 % ) recent acute myocardial infarction previous coronary intervention offlabel indication stenting participation another investigation refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>